GLAXO
GlaxoSmithKline Pharmaceuticals LimitedNSEMarket Closed · NSE · INR
Open
₹2,506.3
High
₹2,510.6
Low
₹2,430
Prev Close
₹2,506.3
Market Cap
₹42.46 K Cr
Large Cap
P/E (TTM)
41.7
EPS
₹60.11
Div Yield
2.27%
P/B Ratio
23.39
ROE
45.3%
Key Metrics
Analyst Ratings(4 analysts)
Target Price
₹2,970
+21.0% upside
Current price: ₹2,455
What If I Had Invested?
Chart data not available for this range
AI Analysis
Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.
AI Technical Analysis
Buy/sell zones with live web research
Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.
Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.
About
GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers adult and pediatric vaccines, such as Shingrix, Havrix, Fluarix Tetra, Varilrix, Infanrix Hexa, Boostrix, Synflorix, Menveo, and Priorix. It also provides...
Technical Indicators
Quality scores
Valuation bands
Intrinsic value calculators
Peer Comparison
Dividend History
Recent: ₹99.00/shareRecent Filings (NSE)
Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.
Institutional Deals(NSE)
Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.
Governance Scorecard
AlphaView compositeFund Actions
News
News sourced from RSS feeds. Headlines link to original articles.
Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.